GlycoMimetics (GLYC) Stock Statistics & Valuation Metrics

GlycoMimetics has a market cap or net worth of $13.49M. The enterprise value is -$5.60B.

GlycoMimetics has 64,532,090 shares outstanding. The number of shares has decreased by -2.65% in one year.

GlycoMimetics’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 0.57%.

The current PE Ratio of GlycoMimetics is -0.42. GlycoMimetics’s PEG ratio is -0.02.

In the last 12 months, GlycoMimetics had revenue of 0.00 and earned -37.88M in profits. Earnings per share was -0.59.

In the last 12 months, operating cash flow was -5.13B and capital expenditures -9.96M, giving a free cash flow of -5.13B billion.

GlycoMimetics pays an annual dividend of ―, resulting in a dividend yield of ―

GlycoMimetics upcoming earnings date is Apr 30, 2026, TBA Not Confirmed.

GlycoMimetics as a current ratio of <0.01, with Debt / Equity ratio of 0.00%

In the past 12 months, GlycoMimetics has paid 0.00 in taxes.

GlycoMimetics EV to EBITDA ratio is -1.91, with an EV/FCF ratio of -2.32.

GlycoMimetics has $5.61B in cash and marketable securities with $0.00 in debt, giving a net cash position of -$5.61B billion.

Gross margin is 27.03%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for GlycoMimetics is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy